- Q4 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 27, 2024₹1120.3 (+8.20%)Earnings
- Q2 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2023₹750.6 (+3.60%)Earnings
- Q1 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 14, 2023₹797.55 (-0.51%)Earnings
- Full Year 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 22, 2023₹605.2 (-3.04%)Earnings
- Q3 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 13, 2023₹422.8 (+5.74%)Earnings
- Q2 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 14, 2022₹430.65 (+3.98%)Earnings
- Q1 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 12, 2022₹389 (+0.82%)Earnings
- Full Year 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 30, 2022₹409.5 (+2.88%)Earnings
- Q3 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 14, 2022₹478.45 (-2.28%)Earnings
- Q2 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2021₹535.75 (+2.31%)Earnings
- Q1 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 16, 2021₹569.4 (+1.10%)Earnings
- Full Year 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 31, 2021₹592.6 (-2.39%)Earnings
- Q3 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 15, 2021₹490.65 (-2.69%)Earnings
- Q2 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 09, 2020₹481.35 (-5.89%)Earnings
- Q1 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 17, 2020₹480.9 (+1.16%)Earnings
- Full Year 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptJun 29, 2020₹467.5 (+0.14%)Earnings
- Hindustan Unilever Ltd to Acquire Intimate Hygiene Brand 'VWash' from Glenmark Pharmaceuticals Ltd Call TranscriptMar 23, 2020
- Q3 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 17, 2020₹310.4 (-6.97%)Earnings
- Q2 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2019₹301.2 (+6.70%)Earnings
- Q1 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 14, 2019₹383.9 (-7.94%)Earnings
- Full Year 2019 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 30, 2019₹555.35 (+1.46%)Earnings
Q2 2024 Glenmark Pharmaceuticals Ltd Earnings Call Transcript
Good morning, ladies and gentlemen. Welcome to the Q2 FY '24 Earnings Conference Call of Glenmark Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Utkarsh Gandhi, General Manager, Investor Relations for Glenmark Pharmaceuticals. Thank you, and over to you, sir.
Thank you, [Lizan]. Good morning, everyone. Welcome to the Q2 FY '24 Results Conference Call of Glenmark Pharmaceuticals Limited. We'll just review the overall performance of the company for the second quarter of FY '24. For the second quarter of FY '24, Glenmark's consolidated revenue from operations was at INR 35,879 million, as against INR 33,752 million in the corresponding quarter last year, recording an overall year-on-year growth of 6.3%. For the 6 months ended September 30, 2023, Glenmark's consolidated revenue was INR 69,895 million as against INR 61,525 million, recording an increase of 13.6%.
Some key updates on the formulation business, starting with India. Sales from the formulation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)